Mainz Biomed Net Worth

Mainz Biomed Net Worth Breakdown

  MYNZ
The net worth of Mainz Biomed BV is the difference between its total assets and liabilities. Mainz Biomed's net worth represents the value of the company's equity or ownership interest. In other words, it is the amount of money that would be left over if all of Mainz Biomed's assets were sold and all of its debts were paid off. Net worth is sometimes referred to as shareholder's equity or book value. Mainz Biomed's net worth can be used as a measure of its financial health and stability which can help investors to decide if Mainz Biomed is a good investment. It is also essential in determining the company's creditworthiness and ability to secure financing before investing in Mainz Biomed BV stock.

Mainz Biomed Net Worth Analysis

Mainz Biomed's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Mainz Biomed's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Mainz Biomed's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Mainz Biomed's net worth analysis. One common approach is to calculate Mainz Biomed's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Mainz Biomed's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Mainz Biomed's net worth. This approach calculates the present value of Mainz Biomed's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Mainz Biomed's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Mainz Biomed's net worth. This involves comparing Mainz Biomed's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Mainz Biomed's net worth relative to its peers.

Enterprise Value

18.23 Million

To determine if Mainz Biomed is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Mainz Biomed's net worth research are outlined below:
Mainz Biomed BV is way too risky over 90 days horizon
Mainz Biomed BV appears to be risky and price may revert if volatility continues
Mainz Biomed BV has high likelihood to experience some financial distress in the next 2 years
Mainz Biomed BVhas  3,566,004  shares shorted by Mainz Biomed investors is about 100% of outstending shares
The company reported the previous year's revenue of 895.48 K. Net Loss for the year was (26.3 M) with profit before overhead, payroll, taxes, and interest of 177.62 K.
Mainz Biomed BV currently holds about 26.01 M in cash with (21.94 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.8.
Mainz Biomed BV has a frail financial position based on the latest SEC disclosures
Latest headline from benzinga.com: Mainz Biomed Announces Reverse Stock Split Soon After Collaborating With MedTech Giant Thermo Fisher Scientific
Mainz Biomed uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Mainz Biomed BV. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Mainz Biomed's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
8th of April 2024
Upcoming Quarterly Report
View
21st of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
8th of April 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Mainz Biomed Target Price Consensus

Mainz target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Mainz Biomed's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
   2  Buy
Most Mainz analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Mainz stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Mainz Biomed BV, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice   Exposure   Valuation

Mainz Biomed Target Price Projection

Mainz Biomed's current and average target prices are 6.79 and 9.67, respectively. The current price of Mainz Biomed is the price at which Mainz Biomed BV is currently trading. On the other hand, Mainz Biomed's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.

Current Price

Mainz Biomed Market Quote on 6th of December 2024

Low Price6.25Odds
High Price7.37Odds

6.79

Target Price

Analyst Consensus On Mainz Biomed Target Price

Low Estimate8.8Odds
High Estimate10.73Odds

9.67

Historical Lowest Forecast  8.8 Target Price  9.67 Highest Forecast  10.73
Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Mainz Biomed BV and the information provided on this page.

Follow Mainz Biomed's market capitalization trends

The company currently falls under 'Micro-Cap' category with a current market capitalization of 14.66 M.

Market Cap

17.9 Million

Project Mainz Biomed's profitablity

Last ReportedProjected for Next Year
Return On Tangible Assets(2.19)(2.30)
Return On Capital Employed(4.32)(4.10)
Return On Assets(1.71)(1.79)
Return On Equity(8.09)(7.69)
When accessing Mainz Biomed's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Mainz Biomed's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Mainz Biomed's profitability and make more informed investment decisions.
Please note, the imprecision that can be found in Mainz Biomed's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Mainz Biomed BV. Check Mainz Biomed's Beneish M Score to see the likelihood of Mainz Biomed's management manipulating its earnings.

Evaluate Mainz Biomed's management efficiency

Mainz Biomed BV has return on total asset (ROA) of (0.9924) % which means that it has lost $0.9924 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (43.3371) %, meaning that it created substantial loss on money invested by shareholders. Mainz Biomed's management efficiency ratios could be used to measure how well Mainz Biomed manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -2.3 in 2024. Return On Capital Employed is likely to rise to -4.1 in 2024. At this time, Mainz Biomed's Non Current Assets Total are fairly stable compared to the past year. Net Tangible Assets is likely to rise to about 7.7 M in 2024, whereas Total Assets are likely to drop slightly above 10.4 M in 2024.
Last ReportedProjected for Next Year
Book Value Per Share 0.20  0.22 
Tangible Book Value Per Share(0.01)(0.01)
Enterprise Value Over EBITDA(0.77)(0.81)
Price Book Value Ratio 5.80  6.09 
Enterprise Value Multiple(0.77)(0.81)
Price Fair Value 5.80  6.09 
Enterprise Value19.2 M18.2 M
Leadership effectiveness at Mainz Biomed BV is a strong indicator of its financial stability. We analyze various metrics to provide insights into the stock's investment viability.
Enterprise Value Revenue
23.0587
Revenue
917.2 K
Quarterly Revenue Growth
0.046
Revenue Per Share
0.046
Return On Equity
(43.34)

Mainz Biomed Corporate Filings

6K
29th of November 2024
A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges.
ViewVerify
5th of November 2024
Other Reports
ViewVerify
13A
7th of October 2024
An amended filing to the original Schedule 13G
ViewVerify
10th of May 2024
Other Reports
ViewVerify
Mainz Biomed time-series forecasting models is one of many Mainz Biomed's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Mainz Biomed's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Mainz Biomed Earnings Estimation Breakdown

The calculation of Mainz Biomed's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Mainz Biomed is estimated to be -8.0 with the future projection ranging from a low of -8.0 to a high of -8.0. Please be aware that this consensus of annual earnings estimates for Mainz Biomed BV is based on EPS before non-recurring items and includes expenses related to employee stock options.
Last Reported EPS
-0.24
-8
Lowest
Expected EPS
-8.0
-8
Highest

Mainz Biomed Earnings Projection Consensus

Suppose the current estimates of Mainz Biomed's value are higher than the current market price of the Mainz Biomed stock. In this case, investors may conclude that Mainz Biomed is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Mainz Biomed's stock will quickly adjusts to the new information provided by the consensus estimate.
Number of AnalystsHistorical AccuracyLast Reported EPSEstimated EPS for 30th of June 2024Current EPS (TTM)
267.35%
-0.24
-8.0
-46.97

Mainz Biomed Earnings per Share Projection vs Actual

Actual Earning per Share of Mainz Biomed refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Mainz Biomed BV predict the company's earnings will be in the future. The higher the earnings per share of Mainz Biomed, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

Mainz Biomed Estimated Months Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as Mainz Biomed, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Mainz Biomed should always be considered in relation to other companies to make a more educated investment decision.

Mainz Quarterly Analyst Estimates and Surprise Metrics

Earnings surprises can significantly impact Mainz Biomed's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2024-04-09
2024-03-31-0.32-0.240.0825 
2024-03-06
2023-12-31-0.3167-0.240.076724 
2023-11-16
2023-09-30-0.47-0.390.0817 
2023-08-15
2023-06-30-0.42-0.56-0.1433 
2023-04-27
2023-03-31-0.46-0.450.01
2023-03-08
2022-12-31-0.46-0.460.0
2022-11-02
2022-09-30-0.43-0.430.0
2022-09-07
2022-06-30-0.46-0.460.0
2022-05-02
2022-03-31-0.49-0.84-0.3571 
2022-01-28
2021-12-310-0.03-0.03
2021-11-12
2021-09-300-0.02-0.02
2021-06-30
2021-03-310-0.1198-0.1198

Mainz Biomed Corporate Management

Additional Tools for Mainz Stock Analysis

When running Mainz Biomed's price analysis, check to measure Mainz Biomed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mainz Biomed is operating at the current time. Most of Mainz Biomed's value examination focuses on studying past and present price action to predict the probability of Mainz Biomed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mainz Biomed's price. Additionally, you may evaluate how the addition of Mainz Biomed to your portfolios can decrease your overall portfolio volatility.